购物车
- 全部删除
- 您的购物车当前为空
AZD5462 是一种有效可口服的松弛素受体 RXFP1 激动剂,可用于研究心力衰竭和癌症。
为众多的药物研发团队赋能,
让新药发现更简单!
AZD5462 是一种有效可口服的松弛素受体 RXFP1 激动剂,可用于研究心力衰竭和癌症。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,880 | 现货 | |
5 mg | ¥ 6,530 | 现货 | |
10 mg | ¥ 8,820 | 现货 | |
25 mg | ¥ 12,900 | 现货 | |
50 mg | ¥ 17,600 | 现货 |
产品描述 | AZD5462 is a potent orally available relaxin receptor RXFP1 agonist for the study of heart failure and cancer. |
靶点活性 | cAMP:17 nM (EC50s), cGMP:50 nM (EC50s) |
体外活性 | AZD5462 (example 1) exhibits stimulatory activity on cAMP or cGMP production with EC50s of 17 nM and 50 nM, respectively[1]. Binding to human plasma proteins with a fraction unbound (free) rate of 4.3%, AZD5462 demonstrates stability with Clint values of 23 μL/min/mg (human liver microsomal), 4.8 μL/min/10^6 cells (human hepatocyte), and 11 μL/min/10^6 cells (rat hepatocyte)[1]. AZD5462 enhances the phosphorylation of ERK with an EC50 value of 6.3 nM[1]. |
分子量 | 544.65 |
分子式 | C30H41FN2O6 |
CAS No. | 2787501-83-9 |
存储 | store at low temperature | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (91.8 mM) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.